# FDA Inspection 1116762 - Recipharm Monts - March 29, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/6d6f7f96-cd3d-4333-9ca1-8e5e161ed82d
Source feed: FDA_Inspections

> FDA Inspection 1116762 for Recipharm Monts on March 29, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1116762
- Company Name: Recipharm Monts
- Inspection Date: 2019-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1181620 - 2022-10-18](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/1e8094d2-a501-42d5-a694-2a4acf3c64b3)
- [FDA Inspection 940945 - 2015-06-09](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/b0930f8a-db4b-4f30-83a8-668fdf63cee8)
- [FDA Inspection 821445 - 2013-02-26](https://www.globalkeysolutions.net/records/fda_inspections/recipharm-monts/940dab1d-4621-41f2-a4a6-6d62b88e1d11)

Company: https://www.globalkeysolutions.net/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c